Seattle biotech firm Shape Therapeutics inks gene therapy deal with Roche worth up to $3B Shape Therapeutics has signed a deal potentially exceeding $3 billion with pharma giant Roche to support the development of gene… Read More
Seattle-based Shape Therapeutics raises $112M to develop RNA-editing and gene therapies Shape Therapeutics, a Seattle preclinical stage biotech company developing RNA editing and gene therapy technologies, has raised $112 million. The… Read More
